Home
Products
COVID-19 POCT
Antigen Rapid Test
VOC-based POCT
Women's Health
Pneumonia
Ainos Pen
AI Nose
Technology
AI Nose
Low-dose interferon
Synthetic RNA
Support
About Us
News
Investors
English
繁體中文
日本語
News Releases
Search by year or by keyword :
Search
Date
Title
2023-08-10
Ainos Celebrates First Listing Anniversary on Nasdaq
2023-08-09
Ainos Partners with Nisshinbo Micro Devices and Inabata to Co-Develop VOC Sensing Platform For Broader Industry Adoption
2023-06-20
Ainos Provides Insights Into Its AI Nose Technology
2023-06-14
Ainos Completes VELDONA Pet Line-Up by Launching New VELDONA Pet Shiny and Slim in Push Towards $20M Revenue Target
2023-06-07
Ainos Launches New VELDONA Pet Lohas and Soothing Health Supplements, Catalyzing Its Drive to $20M Sales Target
2023-05-30
Ainos Launches VELDONA Pet Cytoprotein Health Supplement Targeting $20M in Sales
2023-03-21
Ainos Signs Agreement Establishing Topmed as Exclusive Distributor of VELDONA Animal Health Supplements in Taiwan
2023-03-14
Ainos and Merdury Sign MoU to Explore Phase 3 Study of VELDONA Drug Candidate for Treatment of Oral Warts in HIV-Seropositive Patients
2023-01-23
Ainos and Tah-An Sign MoU to Explore Manufacture of VELDONA Animal Investigational New Drug
2022-11-25
Five New Drug Candidates Show Promise as Ainos Pursues Licensing Partners of its Low-dose Oral Interferon Formulation
«
1
2
3
4
5
6
»
CONTACT US
United States:
8880 Rio San Diego Drive, Suite 800, San Diego, CA 92108
+1 (858) 869-2986
Taiwan:
10F-2, No. 66, Shengyi 5th Rd., Zhubei City, Hsinchu County 302 , Taiwan (R.O.C.)
+886 (0)3-550-5199
COMPANY
Products
AI Nose
Low-Dose Oral Interferon
Synthetic RNA
News
Privacy policy
INVESTORS
Overview
Stock Info
IR News
Governance
Financials
Alerts
OUR AGENTS
INABATA & CO., LTD.
TAIWAN ORIACT CO., LTD.
Copyright © 2023 Ainos Inc. All rights reserved.